Drug Profile
Cipralisant
Alternative Names: GT-2331; PerceptinLatest Information Update: 03 Feb 2017
Price :
$50
*
At a glance
- Originator Gliatech (CEASED)
- Class Antidementias; Antihistamines; Neuroprotectants; Small molecules
- Mechanism of Action Histamine H3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Attention-deficit hyperactivity disorder; Cognition disorders; Sleep disorders
Most Recent Events
- 02 Feb 2017 Discontinued - Phase-I for Alzheimer's disease in USA (PO)
- 02 Feb 2017 Discontinued - Phase-II for Attention-deficit hyperactivity disorder in USA (PO)
- 02 Feb 2017 Discontinued - Phase-II for Cognition disorders in USA (PO)